Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Bacteremia | Phase 1 | ClinicalTrials |
| Asthma; Pulmonary Eosinophilia | Phase 3 | ClinicalTrials |
| HIV Infections | Phase 2/Phase 3 | ClinicalTrials |
| Arthritis, Infectious; Communicable Diseases; Infection | Phase 2 | ClinicalTrials |
| Atherosclerosis; Ischemia; Thromboangiitis Obliterans | Phase 2 | ClinicalTrials |
| Communicable Diseases; Infection; Respiratory Syncytial Virus Infections; Virus Diseases | Phase 2 | ClinicalTrials |
| Anemia; Anemia, Iron-Deficiency | Phase 4 | ClinicalTrials |
| Hepatitis; Hepatitis A; Hepatitis C; Hepatitis C, Chronic; Hepatitis, Chronic | Phase 2 | ClinicalTrials |
| Clostridium Infections; Communicable Diseases; Infection | Phase 3 | ClinicalTrials |
| Clostridium Infections; Communicable Diseases; Infection | Phase 3 | ClinicalTrials |
| Asthma | Phase 3 | ClinicalTrials |
CONTENTS